# Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)

> **NCT03859544** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 74 (estimated)

## Conditions studied

- Central Nervous System Lymphoma

## Interventions

- **OTHER:** Retrospective study

## Key facts

- **NCT ID:** NCT03859544
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859544, "Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03859544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*